Table 1.
Participant characteristics.
| No. of subjects | 231 |
| Male, No. (%) | 127 (55.0) |
| Age, mean ± SD | 55.7 ± 12.1 |
| Age, No. (%) | |
| < 35 years | 20 (8.7) |
| 35–49 years | 41 (17.8) |
| 50–64 years | 111 (48.1) |
| ≥65 years | 59 (25.5) |
| Race, No. (%) | |
| White | 165 (71.4) |
| Black | 19 (8.2) |
| Asian | 11 (4.8) |
| Hispanic | 32 (13.9) |
| Other | 4 (1.7) |
| Diagnosis, No. (%) | |
| A (e.g. Obstructive lung disease) | 37 (16.0) |
| B (e.g. Pulmonary Hypertension) | 10 (4.3) |
| C (e.g. Suppurative lung disease) | 20 (8.7) |
| D (e.g. Pulmonary Fibrosis) | 164 (71.0) |
| BMI (kg/m2) , mean ± SD | 25.5 ± 4.4 |
| FEV1 % predicted, mean ± SD | 45.4 ± 20.5 |
| FEV1 % predicted, median (Q1, Q3) | 46.0 (28.0, 60.0) |
| 6 MWD (m), mean ± SD | 254.4 ± 140.8 |
| 6 MWD (m), median (Q1, Q3) | 268.2 (142.7, 366.0) |
| LAS at transplant, mean ± SD | 58.5 ± 21.5 |
| LAS at transplant, median (Q1, Q3) | 52.0 (39.0, 79.0) |
| Transplant type, No. (%) | |
| Bilateral | 215 (93.1) |
| Single | 13 (5.6) |
| Heart/Lung | 3 (1.3) |
| Inpatient at transplant, No. (%) | 76 (32.9) |
| Ventilator at transplant, No. (%) | 21 (9.1) |
| ECMO at transplant, No. (%) | 18 (7.8) |
| Pre-transplant SPPB, mean ± SD | 9.0 ± 3.1 |
| Pre-transplant SPPB, median (Q1, Q3) | 10.0 (8.0, 11.0) |
| Time to CLAD, years, median (Q1, Q3) | 2.9 (1.6, 4.5) |
SPPB= Short Physical Performance Battery. COPD=Chronic Obstructive Pulmonary Disease, BMI=Body Mass Index, FEV1=Forced Expiratory Volume in the first second, 6 MWD=Six Minute Walk Distance, LAS=Lung Allocation Score, ECMO=Extracorporeal Membrane Oxygenation. Data are presented as number of patients (percentage) or mean ± standard deviation.